73594-0101Level 3
COSELA (trilaciclib)
**Product type:** Human Prescription Drug
**Active ingredient:** TRILACICLIB DIHYDROCHLORIDE
**Strength:** 300 mg/20mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Pharmacosmos Therapeutics Inc.
**Marketing category:** NDA (NDA214200)
**Pharmacologic class:** Cyclin-dependent Kinase 4 Inhibitors [MoA], Cyclin-dependent Kinase 6 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/73594-0101Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.